Journal of Clinical Oncology

Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at <i>JCO</i> : A Guide for Studies Testing Artificial Intelligence Models

R Ravi B. Parikh (Department of Hematology and Medical Oncology, Emory University, Atlanta) A Alexia Iasonos A Andrew Ko (University of California, San Francisco Cancer Center, San Francisco, CA) J Jeremy Warner (Legorreta Cancer Center, Brown University, Providence, RI) K Kathy Miller (Indiana University School of Medicine, Indianapolis) J Jonathan W. Friedberg (18Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 32
Published November 10, 2025
Pages 3434-3438
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (6)

R

Ravi B. Parikh

Department of Hematology and Medical Oncology, Emory University, Atlanta

A

Alexia Iasonos

A

Andrew Ko

University of California, San Francisco Cancer Center, San Francisco, CA

J

Jeremy Warner

Legorreta Cancer Center, Brown University, Providence, RI

K

Kathy Miller

Indiana University School of Medicine, Indianapolis

J

Jonathan W. Friedberg

18Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001